Type 1 diabetes and risk of heart failure: a systematic review and meta-analysis
M Haji, S Erqou, GC Fonarow, JBE Tcheugui - Diabetes Research and …, 2023 - Elsevier
Aim Robust data on type 1 diabetes (T1DM) and the risk of heart failure (HF) is scarce.
Methods We searched PubMed and EMBASE for relevant studies, abstracted data on HF …
Methods We searched PubMed and EMBASE for relevant studies, abstracted data on HF …
Diabetes and cardiovascular complications: the epidemics continue
R Lopez-Diez, L Egana-Gorrono, L Senatus… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review The cardiovascular complications of type 1 and 2 diabetes are
major causes of morbidity and mortality. Extensive efforts have been made to maximize …
major causes of morbidity and mortality. Extensive efforts have been made to maximize …
30-Year cardiovascular disease in type 1 diabetes: risk and risk factors differ by long-term patterns of glycemic control
RG Miller, TJ Orchard, T Costacou - Diabetes Care, 2022 - Am Diabetes Assoc
OBJECTIVE We hypothesized that there is heterogeneity in long-term patterns of glycemic
control with respect to cardiovascular disease (CVD) development in type 1 diabetes and …
control with respect to cardiovascular disease (CVD) development in type 1 diabetes and …
Increased prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes and hypertension: The SWEET international database
A Vazeou, SR Tittel, O Kordonouri… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aims To investigate the prevalence of modifiable cardiovascular risk factors (CVRFs),
including dyslipidaemia, obesity and high glycated haemoglobin (HbA1c) concentration, in …
including dyslipidaemia, obesity and high glycated haemoglobin (HbA1c) concentration, in …
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs
GB Bolli, F Porcellati, P Lucidi, CG Fanelli, DR Owens - Metabolism, 2022 - Elsevier
The first insulin preparation injected in humans in 1922 was short-acting, extracted from
animal pancreas, contaminated by impurities. Ever since the insulin extracted from animal …
animal pancreas, contaminated by impurities. Ever since the insulin extracted from animal …
Cardiovascular risk factors in children and adolescents with type 1 diabetes mellitus: The role of insulin resistance and associated genetic variants
Abstract Introduction: Type 1 diabetes (T1D) is associated with an increased risk of
cardiovascular disease. Insulin resistance is an important cardiovascular risk factor (CVRF) …
cardiovascular disease. Insulin resistance is an important cardiovascular risk factor (CVRF) …
The associations of risk of cardiovascular disease with development stages of diabetes in Chinese population: findings from a retrospective cohort study in QuZhou …
Q Wang, Z Gan, Q Gao, M Wang, B Zhan - BMC Endocrine Disorders, 2024 - Springer
Background Risk analysis is an important area of research in diabetes and cardiovascular
disease (CVD), both of which have significant global health burdens. Although there is …
disease (CVD), both of which have significant global health burdens. Although there is …
Ранняя интенсификация терапии сахарного диабета 2 типа и достижение целевого уровня гликогемоглобина HbA 1c—необходимые факторы для снижения …
МШ Шамхалова, ОЮ Сухарева - Сахарный диабет, 2023 - dia-endojournals.ru
Аннотация Контроль сахарного диабета 2 типа (СД2) требует многофакторного
поведенческого и фармакологического лечения для предотвращения развития или …
поведенческого и фармакологического лечения для предотвращения развития или …
Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA 1c are necessary factors to reduce the risk of …
MS Shamkhalova, OY Sukhareva - Diabetes mellitus, 2023 - dia-endojournals.ru
Control of type 2 diabetes mellitus (T2DM) requires multifactorial behavioral and
pharmacological treatment to prevent the development or slow the progression of …
pharmacological treatment to prevent the development or slow the progression of …
Exploring the potential quality marker of traditional tibetan medicine Erigeron multiradiatus based on ultra-high performance liquid chromatography-quadrupole time …
A Hamamozhi, J Li, X Su, W Cai, R Zhao… - Pharmacognosy …, 2022 - phcog.com
Background: Erigeron multiradiatus (EM), a well-known traditional Tibetan medicine, has
been used for hundreds of years to treat various chronic metabolic diseases. However …
been used for hundreds of years to treat various chronic metabolic diseases. However …